Details efforts VaxGen and its president, Don Francis, to obtain permission to conduct a Phase III clinical trial in Thailand AIDSVAX, an experimental vaccine designed to protect against the human immunodeficiency virus (HIV), the virus that causes AIDS. Francis must struggle with a lot of ethical questions on how certain he should be on the effectiveness of AIDSVAX, to ensure the participation of thousands of subjects in clinical trials, to any type of compensation or treatment, if any, to offer volunteer subjects in developing countries, where standard for the treatment of AIDS are significantly lower than in the United States. "Hide
by Margaret L. Eaton, Jennifer Wilds, Betty Pang Source: Stanford Graduate School of Business 23 pages. Publication Date: February 15, 2005. Prod. #: BME1-PDF-ENG
Related Case Solutions & Analyses:
NovoCure Ltd.
Sullivan Container
Marineland and the Mayor
Patricia Coulter’s Dilemma (A)
Ten Years Later: Memoirs of Life and Work a Decade after an MBA
Congruence Model Note
Dealing With A Toxic Boss C
Yvette Hyater-Adams and Terry Larsen at CoreStates Financial Corp.
Amy Biehl Foundation Trust
Professional Services Course
